|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Quality of primary care guidelines for acute low back pain显示文摘 | van Tulder M W Tuut M Pennick V | | 0，，17： | 1 |
| 2 | Development and validation of a high-performance liquid chromatography assay for voriconazole 显示文摘 | PENNICK GJ CLARK M SUTTON DA | 2003 | Antimicrob Agents Chemother2003，47，7： | 1 |
| 3 | Develo- pment and validation of a high-performance liquid chromatography assay for voriconazole 显示文摘 | PENNICK G J CLARK M SUTTON D A | 2003 | Antimicrob Agents Chemother2003，47，7： | 1 |
| 4 | Development and validation of a high-performance liquid chromatography assay for vorieonazole显示文摘 | Pennick G J Clark M Sutton DA | 2003 | Antimicrob Agents Chemother2003，47，7： | 1 |
| 5 | Bioavailability of triple- bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release 显示文摘 | Ermer JC Shojaei A Pennick M | 2007 | Curr Med Res Opin2007，23，5： | 1 |
| 6 | Clinical pharmacokinetics of the phos-phate binder lanthanum carbonate 显示文摘 | Damment SJ Pennick M | 2008 | Clin Pharmacokinet2008，47，9： | 1 |
| 7 | Development and validation of a high-performance liquid chromatography assay for voriconazole显示文摘 | Pennick G J Clark M Sutton D A | 2003 | Antimicrob Agents Chemother2003，47，7： | 1 |
| 8 | A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1 -,2-, and 4-rag tablets in healthy adults 显示文摘 | Swearingen D Pennick M Shojaei A | 2007 | Clin Ther2007，29，4： | 1 |
| 9 | Clinical pharmacokinetics of the phosphate binder lanthanum carbonate显示文摘 | Damment S J Pennick M | 2008 | Clin Pharmacokinet2008，47，： | 1 |
| 10 | A phaseI,randomized, open-label, crossover study of the single-dosepharmacokinetic properties of guanfacine extended-release 1 -, 2-,and 4-mg tablets in healthy adults 显示文摘 | SWEARINGEN D PENNICK M SHOJAEI A | 2007 | Clin Ther2007，29，4： | 1 |
| 11 | Clinical pharmacokinetics of the phosphate binder lanthanum carbonate显示文摘 | Damment SJ Pennick M | 2008 | Clin Pharmacoki- net2008，47，9： | 1 |
| 12 | Clinical pharmacokinetics of the phosphate binder lanthanum carbonate显示文摘 | Damment S J Pennick M | | 0，，： | 1 |
| 13 | Lanthanum carbonate reduces urine phosphorus excretion:evidence of high-capacity phosphate binding显示文摘 | Pennick M Poole L Dennis K | 2012 | Ren Fail2012，34，3： | 1 |
| 14 | Systemic lanthanum is excreted in the bile of rats显示文摘 | Damment S J P Pennick M | 2007 | Toxicology letters2007，171，12： | 1 |
| 15 | Development and validation of a high-performance liquid chromatography assay for voriconazole显示文摘 | Pennick GJ Clark M Sutton DA | 2003 | Antimierob Agents Chemother2003，47，7： | 1 |
| 16 | Clinical pharmacokinetics of the phosphate binder lanthanum carbonate显示文摘 | Damment S J P Pennick M | 2008 | Clinical Pharmacokinetics2008，47，9： | 1 |
| 17 | A model of the kinetics of lanthanum in human bone,using data collected during the clinical development of the phosphate binder lanthanum carbonate显示文摘 | Bronner F Slepchenko B M Pennick M | 2008 | Clinical Pharmacokinetics2008，8，： | 1 |
| 18 | Systemic lanthanum is excreted in the bile of rats显示文摘 | Damment SJ Pennick M | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员